- Why You And Your Pooch Share Similar Reactions to Life
- How to Gauge Your Personal Risk For a Hernia
- Journalists Talk Medicaid Work Mandate in Georgia and Wage Garnishment Bill in Colorado
- How NYU Langone built 1 of the nation’s fastest-growing GI divisions
- BCBS study: Hospital AI billing tools may be driving up healthcare costs by billions
- The transition gap: How RCA is using recovery housing to prevent relapse
- CMS moves forward with 3rd round of Medicare drug negotiations
- Kroger pharmacies add Zepbound KwikPen
- Nurses navigate AI-generated health information at bedside
- Louisiana senator resumes push to repeal water fluoridation program
- HCA’s highest-earning executives in 2025
- HCA’s highest-earning executives in 2025
- CHS Alabama hospital CEO heads to Florida
- RWJBarnabas New Jersey hospital taps new COO
- Why some health system CEOs are opting out of cross-market expansion
- Stanford Health Care leader to advise agentic AI startup
- Piedmont, Encompass tap CEO for planned Georgia hospital
- Inside Virginia’s 1st ‘tri-accredited’ bariatric surgery center
- The red flags DSOs can’t afford to ignore
- About 82% of public Medicare Advantage rate notice comments tied to ‘dark money’ group: KFF
- 10 federal government, policy updates for dentists to know
- The highest-paid ophthalmologist in the 10 largest Northeastern cities
- Arizona cardiology group pays $4.75M to settle false claims allegations
- Why AI is keeping dental practice owners up at night
- OSF HealthCare uses text outreach after ED visits — and sees 33% engagement
- Medicare spending on ASCs jumps 16% in 1 year: MedPAC
- The uneven competition in physician markets
- ‘Dark Money’ Group Angles for Higher Medicare Advantage Payments
- Judge grants Mississippi hospital pause on Medicaid debt repayment
- Inside the erosion of independence in cardiology
- OIG green-lights ASC cataract supply discount proposal
- Children’s Hospital of Philadelphia anesthesiologist receives lifetime achievement award
- Oceans Behavioral Hospital debuts virtual outpatient program
- UF Health opens 24K-square-foot orthopedic surgical center
- Illinois health association to open $4M dental practice
- 30+ dental industry updates in California, Florida and Texas
- Heartland Dental expands in 4 states
- Crestwood Behavioral Health names program chief
- Dartmouth hospital launches social work department
- Georgia health system launches new digital patient billing system
- 5 DSOs making headlines
- Oceans behavioral health hospital taps CEO
- Amazon launches health AI agent on its website, expands free virtual care to 200M Prime members
- Pediatric dental, orthodontic practice building sold for $4.4M
- San Francisco secures $100M to expand behavioral health treatment to 3 sites
- How nursing backgrounds shaped 2 revenue cycle leaders
- Study Finds 'Forever Chemicals' on California Fruits and Vegetables
- Bad News for Multitaskers: Your Brain Can’t Really Do It
- OSF HealthCare uses digital therapeutics to create a digital path to care
- Former Tenet CFO joins Acadia Healthcare board
- About 3,000 Wayfair Dressers Recalled Over Child Tip-Over Risk
- Microsoft Unveils AI Health Tool That Can Read Your Medical Records
- FDA Town Hall: FDA’s Quality Management System Regulation (QMSR) – Medical Device Risk-Based Inspections
- FDA Town Hall: FDA’s Quality Management System Regulation (QMSR) – Medical Device Risk-Based Inspections
- The feds will overpay Medicare Advantage plans by $76B this year, MedPAC estimates
- FDA Launches New Adverse Event Look-Up Tool
- FDA Launches New Adverse Event Look-Up Tool
- FDA Issues Final Guidance on Medical Devices with Indications Associated with Weight Loss
- FDA Issues Final Guidance on Medical Devices with Indications Associated with Weight Loss
- The 510(k) Pathway in 2026: Navigating a Shifting Regulatory and Political Landscape for Medical Devices
- The 510(k) Pathway in 2026: Navigating a Shifting Regulatory and Political Landscape for Medical Devices
- Bayer found to have discredited pharma industry after Roche row
- Industry Voices—Fast answers, fragile data: the trust problem in AI-driven healthcare analytics
- Pfizer CEO Albert Bourla collects $27.6M in 2025 pay following Metsera, MFN deals
- GSK catches up to Pfizer, Moderna with FDA expansion for Arexvy
- Experts Weigh in on Digital Health Wearables for Neurological Health
- Ultra-Processed Foods Bad For Bone Health, Researchers Say
- AI-Generated Meal Plans For Dieting Teens Could Be Harmful, Study Warns
- Fertility Treatments Aren't Linked To Added Cancer Risk For Women, Study Concludes
- There's One Simple Way Cancer Patients Can Ward Off 'Chemo Brain,' Study Finds
- Younger Stroke Survivors Face Unique Mental Health Hurdles
- 'Manufacturing is access': How Gilead's early production moves set PrEP med Yeztugo up for success
- Families Scramble To Pay Five-Figure Bills as Clock Ticks on Promised Preauthorization Reforms
- Medicare Advantage ‘Dark Money’ Group Attempts To Win Higher Payments for Insurance Companies
- Doctors Warn of a Deadly Complication From Measles Outbreaks
- FDA scolds CDMO Simtra with warning letter over contamination fumbles
- FDA fires off another manufacturing-related CRL, this one to Hyloris
- Hospital margins take a dive
- Florida woman accused of operating illegal dental clinic out of home
- North Carolina updates mental health bed registry
- Medicare Advantage spending 14% higher than fee for service: Report
- Washington hospital to close pediatric rehab clinic
- New Jersey system partners with health center ahead of ED closure
- What the Health? From KFF Health News: RFK Jr.’s Very Bad Week
- Report on doctor's sexual abuse spurs promises of structural change at Columbia. Survivors say it isn't enough
- Dana-Farber boosts operating margin to 8.4% in Q1
- Fierce Pharma Asia—A trio of Lilly investments; Pfizer, Sciwind's GLP-1 nod; Astellas' MFN windfall
- Remarks at the Investor Advisory Committee Meeting
- Pediatric Allergy Specialist: Feed Babies Allergenic Foods Earlier, Not Later
- FDA Warns Novo Nordisk Broke Safety Reporting Rules
- Doctors Warn Patients to Research Cosmetic Surgery Providers Before Getting Work Done
- Adam’s Lib: Remarks at the Meeting of the SEC Investor Advisory Committee
- Remarks for the Investor Advisory Committee Meeting
- Gallup poll: One in three Americans cutting back on daily expenses to pay for healthcare
- AMA: Physicians' use of AI doubled from 2023 to 2026
- Study Suggests Epilepsy Drug Sulthiame May Help Treat Sleep Apnea
- At HIMSS26, Dr. Oz, CMS officials push agentic AI adoption. Are Medicare beneficiaries ready?
- Stryker Cyber Attack Being Reported as Iranian War Retaliation
- Stryker Cyber Attack Being Reported as Iranian War Retaliation
- After China outlay, Lilly plugs $126M into Japan manufacturing plant expansion
- Legend remains bullish on Carvykti growth despite threat from J&J’s Tecvayli
- FDA rolls out new streamlined adverse event monitoring system, eyes $120M in savings
- Eisai chooses 'Pokémon Sleep' app to battle bad sleep habits in awareness campaign
- Electrodes Partially Restore Movement, Sensation In Spinal Cord Patients
- Genetic Test May Predict Leukemia Relapse Risk
- Switching GLP-1 Medications Is Common, Can Help People Stick With Weight-Loss Treatment
- Millions Of Americans Making Financial Sacrifices To Afford Health Care, Survey Finds
- More Concussions Linked To Worse Brain Health Among Recent College Grads
- Years of Specialized Support Essential with Rare Heart Defects
- In latest compounding clash, Lilly flags high levels of 'impurity' in tirzepatide knockoffs with vitamin B12
- New Medicaid-focused doula provider Malama launches with $9.2M
- Republicans Fret Over RFK Jr.’s Anti-Vaccine Policies While MAHA Moms Stew
- As Lung Disease Threatens Workers, Lawmakers Seek Protections for Countertop Manufacturers
- Rare disease drug sales to surge past $400B by 2032 despite FDA volatility: Evaluate report
- Microsoft unveils Copilot Health as an AI health companion for consumers
- HIMSS26: HHS officials offer updates on interoperability efforts, information blocking enforcement
- Despite insurers' expense pains, Tenet Healthcare is securing healthy commercial rates through 2027
- Study Links State Taxes to COVID Lockdown Decisions
- Aetna to pay $117.7M to settle Medicare Advantage upcoding allegations: DOJ
- UPDATED: Stryker hit by international cyberattack linked to pro-Iran group
- AHA: Hospitals' total expenses rose by 7.5% in 2025
- AstraZeneca recruits Joshua Jackson, Philadelphia Flyers' Gritty to cancer screening push
- As Lilly flourishes in Q4, peer projections signal looming sector slowdown in 2026
- FDA May Allow Some Flavored Vapes Aimed at Adults
- Dark Sweet Cherries May Help Slow Aggressive Breast Cancer, Mouse Study Suggests
- FDA Approves Leucovorin for Rare Brain Disorder, Not Autism
- Joint Economic Committee report: Medicare Advantage overpayments drive up Part B premiums
- Veeva shells out $100M for Ostro and its AI chat tool for pharma brand engagement
- Lilly beefs up oral GLP-1 capacity with $3B manufacturing pledge in China
- UCB's Bimzelx continues winning streak with victory over AbbVie's Skyrizi
- Lowering Parents' Stress Can Reduce Risk Of Childhood Obesity
- Multilingualism Might Not Aid Brain Aging, Researcher Argues
- 15-Year Study Shows Sharp Rise in Depression Among U.S. College Students
- Repealing Motorcycle Helmet Laws Leads to More Severe Crashes, Millions in Added Treatment Costs
- Why Childhood Cavities May Predict Adult Heart Disease
- Physical Therapy Costs Vary Widely In U.S., Study Finds
- J&J's Joaquin Duato joins $30M CEO pay club with 30% compensation boost for 2025
- Cosmetic Surgery Investigation Prompts Warnings for Patients, and a Push for Tighter Safety Standards
- Primary Care Is in Trouble. So Doctors Band Together To Boost Their Market Power.
- Skyhawk taps Teva alum to steer commercial path, while Santhera names new CCO to grow DMD sales
- Driving the news at HIMSS26: Verily, Samsung ink collaboration; Meditech's latest AI solutions
- Remarks at the Institute of International Bankers 2026 Annual Washington Conference
- Fostering Regulatory Harmony Between the SEC and CFTC
- Here's where hospital markets are the most concentrated
- A look at how CVS is leaning on 'agentic twins' in developing consumer tech
- Patent expirations push biopharma industry toward a tougher 2026
- Sandoz to set up standalone biosimilars unit as it eyes upcoming 'golden decade' of patent losses
- AbbVie's Robert Michael earns hefty pay bump to $32.5M in 2nd year as CEO
- NYU Stern report calls for private equity reforms to safeguard quality of care
- Remarks at the International Bar Association’s 24th Annual International Conference on Private Investment Funds
There have been leadership changes announced at several U.S. Department of Health and Human Services (HHS) agencies:
https://thehill.com/policy/healthcare/5744237-kennedy-reshapes-hhs-leadership/
NIH director Bhattacharya to temporarily serve as CDC director
By Sophie Brams - February 18, 2026Director of the National Institutes of Health Jay Bhattacharya will serve as interim director of the Centers for Disease Control and Prevention (CDC) following the reported exit of Jim O’Neill, a Trump administration official confirmed Wednesday.
It was reported last week that O’Neill, who also served as deputy secretary of the Department of Health and Human Services (HHS), would be leaving his post as part of a broader staff restructuring within the department.
O’Neill is expected to be nominated by President Trump to lead the National Science Foundation, according to The New York Times, which first reported the news of Bhattacharya’s new role.
The shake-up at HHS comes as the Trump administration is sharpening its message on health care ahead of the midterms, hoping Secretary Robert F Kennedy Jr.’s efforts to reshape federal health policy over the past year will resonate with voters and help deliver Republican wins come November.
Other leadership shifts include Centers for Medicare and Medicaid Services (CMS) Deputy Administrator Chris Klomp taking on the role of chief counselor at HHS, and John Brooks transitioning from CMS deputy administrator and chief policy and regulatory officer to CMS senior counselor.
At the Food and Drug Administration (FDA), Deputy Commissioners Kyle Diamantas and Grace Graham were also given new posts as senior counselors.
“In just over a year, we have driven historic progress on President Trump’s health care priorities and delivered real, measurable change,” Kennedy said in a Feb. 12 statement announcing the changes.
“We are restoring accountability, challenging entrenched interests, and putting the health of the American people first. I am proud to elevate battle-tested, principled leaders onto my immediate team—individuals with the courage and experience to help us move faster and go further as we work to Make America Healthy Again,” he added.
The CDC itself has seen abrupt leadership changes over the past year, including the ouster of Director Susan Monarez last August, who was fired less than a month into the job after she refused pressure from the White House to resign.
Bhattacharya, a Stanford University professor, is now poised to take the helm at a time when the agency has come under scrutiny for its shifts to vaccination policies and recommendations.
He said during a Senate hearing last week that he had not seen any studies supporting a potential connection between any vaccine and autism, disputing a theory often peddled by Kennedy.
Bhattacharya is slated to serve as interim director until the U.S. Senate confirms a permanent successor.
After falsely savaging Dr. Jay Bhattacharya during the pandemic, the health care Deep State is now terrified of him:
https://thehill.com/policy/healthcare/5748218-bhattacharya-cdc-nih-leadership-concern/
Bhattacharya’s growing power in Trump’s HHS worries health experts
By Joseph Choi - February 22, 2026Public health experts and former federal staffers are uneasy over National Institutes of Health (NIH) Director Jay Bhattacharya’s rising influence over U.S. health policy as he temporarily takes on the added role of leading the Centers for Disease Control and Prevention (CDC).
The Trump administration announced the leadership shake-up this week, with former interim CDC Director Jim O’Neill being moved out of the Department of Health and Human Services (HHS).
“Candidly, this is someone who very clearly has an ax to grind with science and the scientific community in general,” Kayla Hancock, director of Protect our Care’s Public Health Watch project, said of Bhattacharya.
“We’ve seen with his record already at NIH and his history of Covid denialism before he even took this office that this is just not the kind of person that we need at the helm of our key public health and medical research institutions.”
Bhattacharya, confirmed as NIH director in March of last year, was a Stanford University professor of medicine before joining the Trump administration. He was also one of the lead authors of “Great Barrington Declaration,” a 2020 open letter calling for COVID-19 lockdowns to be rolled back.
In an email to CDC staff on Friday, Bhattacharya laid out what he said was a plan to restore trust in public health. During the pandemic, he wrote, it was “undeniable that some of the Federal government’s decisions, communications, and processes contributed to confusion, frustration, and a loss of that trust.”
“I also recognize the unique challenges faced by each of you over the past year due to abrupt changes in leadership, the tragic act of violence last summer, and overall uncertainty felt by all of you,” wrote Bhattacharya, referring to the fatal shooting at the CDC’s headquarters last year. “One of my goals is to ensure that you all get the recognition you deserve for your efforts.”
He listed three principles the agency would follow under his rule: updating guidance “transparently” as new data emerges, ensuring every investigation it conducts reflects the “responsibility to the communities we serve” and strengthening internal review processes to enhance “accountability and openness.”
The position of CDC director has been haphazardly filled over the past year. President Trump’s first pick, former Florida Rep. David Weldon (R), failed to gain support in the Senate, leading to longtime federal scientist Susan Monarez, the interim director, receiving the nomination to fill the role permanently.
Monarez was ultimately confirmed by the Senate along party lines, but only weeks later the administration pushed her out, with her claiming it was due to her refusal to give blanket approval of recommendations from the CDC’s Advisory Committee on Immunization Practices, which Health and Human Services Secretary Robert F. Kennedy Jr. had restaffed with ideological allies.
O’Neill, a deputy HHS secretary, was then made the interim director, making Bhattacharya the third acting CDC director in seven months.
Former CDC physician Elizabeth Soda, who resigned late last year, said the American public is suffering because of the lack of stable leadership within the agency.
She noted how Congress had largely maintained funding for the agency, rejecting calls by the administration to deeply cut appropriations, indicating the legislative branch recognizes the importance of a strong CDC.
“How can you even do the work that they’re being given the money to do, right? That’s a big challenge, and without having clear leadership, who can really devote the time and energy and expertise to face these challenges head on?” Soda said.
Former federal staffers and public health voices who spoke with The Hill said the NIH and CDC agencies are too large and distinct from one another to have one individual leading both at the same time.
“I don’t think Jay Bhattacharya can be trusted to lead either. But I think the size of both of these organizations and the missions are different, and I think it takes a specific type of person, a single person, to do each of these jobs,” said James Alwine, coordinating committee member of the nonprofit volunteer network Defend Public Health and professor emeritus of cancer biology at the University of Pennsylvania School of Medicine.
The NIH’s primary objective is to support U.S. research infrastructure, while the CDC is largely tasked with surveilling and addressing disease threats.
Alwine began his career at the NIH. He opined that Bhattacharya’s motivations to lead these agencies did not align with their missions of promoting and protecting public health.
“I think some of the things he’s doing certainly look to me like he’s getting back at those who came down on him because they criticized him so much about the Great Barrington Resolution,” Alwine said.
When reached for comment, HHS spokesperson Emily Hilliard said of Bhattacharya, “The Director has empowered the NIH leadership team to ensure the agency’s priorities continue moving forward until the President nominates and the Senate confirms a permanent CDC director.”
“CDC Principal Deputy Director Ralph Abraham and other members of the CDC leadership team will work closely with Dr. Bhattacharya during this acting period to continue protecting and serving the American people,” Hilliard added. “The Director is solely focused on ensuring a seamless transition for both agencies while maintaining continuity of leadership and advancing their core public health missions.”
Monarez, the only confirmed CDC director in Trump’s second term, was an outlier when it came to health nominees. She did not come from the “Make America Healthy Again” (MAHA) antiestablishment world that many of Kennedy’s picks came from, having been a government scientist for decades.
Her refusal to bend completely to the MAHA agenda seemingly played a significant part in her termination.
With Bhattacharya’s temporary dual role, public health influence has become further consolidated among ardent Kennedy allies. Whether Trump and Kennedy can find a MAHA ally who can also win Senate confirmation as CDC director remains to be seen.
Soda, the former CDC staffer, was hopeful that compromises could be made for the sake of stable leadership at the agency.
“The optimist in me can hope,” Soda said. “We have to come to some middle ground understanding with one another, where we may not fully agree completely. But wouldn’t it be great if we could try to start moving towards the middle.”
“In some ways, MAHA’s beliefs, I think, are just so contrary to what CDC represents,” Soda added. “It would be difficult, I think, to find someone who’s a true sort of believer in those principles to also then come and successfully lead the agency that is, you know, the agency that is driven by scientific evidence and data.”
😎 Coming to a theater near you: Jay Bhattacharya, the movie!
https://www.politico.com/news/2026/02/22/the-next-hollywood-hero-jay-bhattacharya-00791313
RFK Jr.’s billionaire running mate is making a comedy about the pandemic
Nicole Shanahan has recruited a top screenwriter and enlisted Covid contrarian Jay Bhattacharya.
By Kelly Hooper - February 22, 2026Covid contrarians tight with Robert F. Kennedy Jr. are pitching Hollywood on an unlikely leading man: National Institutes of Health Director Jay Bhattacharya.
Nicole Shanahan, Kennedy’s running mate in the 2024 presidential campaign, is searching for investors to fund a movie that pokes fun at the pandemic response with a star based on Bhattacharya, who rose to prominence with his anti-lockdown manifesto and relentless tweets opposing social distancing.
The script for the satirical comedy, “The Rash,” is by renowned author Walter Kirn, who wrote the novel “Up in the Air” that became an Oscar-nominated movie starring George Clooney. The new Kirn screenplay stars a “no-nonsense” public health professor at a Stanford-like California university — mirroring Bhattacharya — who speaks out against mass hysteria amid a mysterious outbreak of a contagious skin condition.
The story of the pandemic is one “of great heroes who stood up and said no” to “dangerous scientific experiments mixed with misleading propaganda, mass psychosis, and outright lies,” says the Brownstone Institute in a recent appeal sent to potential funders of the film.
The think tank that once counted Bhattacharya as a senior scholar added that “investors are terrified of the topic and Hollywood elites don’t even want it made.”
The push to make the film is among numerous examples, since President Donald Trump returned to office, in which the president or his allies have sought approbation from America’s culture-making institutions. They’ve had some success. Trump allies renamed the Kennedy Center in Washington to honor him in December and Amazon released a film last month about first lady Melania Trump.
Since 2020, a number of figures in Trump’s orbit have been involved in the creation and promotion of films criticizing public officials’ response to the pandemic or pushing fringe theories about it or vaccines.
Jeffrey Tucker, Brownstone’s founder and president, didn’t respond to requests for comment. In October 2020, he convened a group of scientists, including Bhattacharya, who wrote the Great Barrington Declaration opposing Covid lockdowns. It set off a vigorous debate about the pandemic response and prompted Bhattacharya’s predecessor at NIH, Francis Collins, to call him a “fringe epidemiologist.”
Bhattacharya, whom Kennedy also named acting director of the Centers for Disease Control and Prevention on Wednesday, is on board with the movie, an NIH spokesperson told POLITICO.
“Dr. Bhattacharya has spoken positively about the work Walter Kirn is doing, noting that the project reflects a strong commitment to free speech and open inquiry, and he welcomes thoughtful creative efforts that engage with these issues,” the spokesperson said.
Bhattacharya declined to comment. He’s spent at least 10 hours speaking to Kirn, who shares his views on the handling of the pandemic, for the film.
Shanahan is an executive producer of “The Rash” along with her partner, Jacob Strumwasser, according to Brownstone. Neither Shanahan nor Strumwasser could be reached for comment. Shanahan, a lawyer and entrepreneur, is reportedly a billionaire following her divorce three years ago from Google founder Sergey Brin. While married to Brin, she founded a philanthropy that focuses on extending women’s fertility.
Funding for “The Rash” nonetheless remains an obstacle. The estimated production budget is close to $6 million, according to a slide deck on Brownstone’s website.
Brownstone “is well-positioned to be a fiscal sponsor of this effort,” and the project “already has a top production company lined up along with some notable talent to make a first-rate film,” the website says.
In September, Kirn released a short teaser trailer for “The Rash” on social platform X, saying the film is in the financing phase and interested investors should contact him.
Kirn did not respond to a request for comment.
He said in the X post that he wrote the film for Shanahan and 0nset Creative, an independent production company founded by Alex Lee Moyer, a filmmaker whose credits include a 2022 documentary on far-right conspiracy theorist Alex Jones. In September, as a guest on Shanahan’s podcast, Moyer described the Jones documentary as a film about Covid, the “runway to Jan. 6” and “how off the rails the world went during that moment.”
Three pages of the script for “The Rash” are previewed on Brownstone’s website. In one scene, the governor of California and a character named Dr. Roman Fox orchestrate a celebrity singalong amid the outbreak. A “succession of celebs sing lines from the song ‘Aquarius’ by the Fifth Dimension,” the script reads.
“Some sing beautifully, some not,” the screenplay says. “Behind them are their yards and homes. One sings naked with his crotch blurred out, his body gleaming with oil.”
The song, a No. 1 hit in 1969 based on numbers from the musical Hair, previews a time when Jupiter aligns with Mars and “peace will guide the planets and love will steer the stars.”
The scene appears to poke fun at a celebrity singalong of the John Lennon song “Imagine” during the early days of the Covid pandemic, spearheaded by actress Gal Gadot. At the time, the viral video was widely criticized as elitist and out of touch.
0nset Creative was “established in response to a landscape where media has become decentralized and old models are buckling under the weight of the times,” its website says. The studio is working on a handful of other projects in addition to “The Rash,” including “the first in depth documentary about Silicon Valley and its denizens” and another documentary on unidentified flying objects.
During the September podcast interview with Moyer, Shanahan said she and her partner, Strumwasser, had the “stupid idea” for a satire film inspired by the Covid pandemic and decided to run with it.
“We were like, ‘Wouldn’t it be great if we could just laugh about how ridiculous this all was and how awful it all was?’ But also laugh at it because that means that it’s in the past,” she said.
Moyer said Shanahan approached 0nset Creative with the idea.
“I got to thinking, ‘Well, who’s the best person who can work on this? Who can write a script that’s worthy of this topic?’ And I thought of my good friend, Walter Kirn,” said Moyer.
Shanahan and Strumwasser gave Kirn creative liberty to tell the story in the way he wanted, and he came back with the script for “The Rash,” Moyer added.
Moyer said “The Rash” reminds her of conspiracy thrillers from the ‘60s and ‘70s like “Dr. Strangelove” and “Network,” as well as “some of the lighter influences from films in the ‘90s” like “Wag the Dog” and “Thank You for Smoking.”
“We need to be able to have a sense of humor about our collective trauma,” Moyer told Shanahan.
0nset Creative did not respond to a request for comment, and Moyer could not be reached.
A second scene in the script features a conversation between Fox and “Dr. Neal Chandra,” the character based on Bhattacharya. Fox declares “I’m the science” during the scene — an apparent reference to a 2021 interview in which Anthony Fauci, who led the U.S. pandemic response, said his critics were “really criticizing science because I represent science.” Fox encourages Chandra to sign a document supporting that statement. Chandra refuses.
In a description of the film’s cinematography, the slide deck on Brownstone’s website says the movie will “toggle between composed shots that reflect Dr. Chandra’s rational perspective and looser, handheld coverage that captures the surrounding chaos: influencers melting down on livestreams, press conferences spinning off-script, executives high on their own power.”
“The world bends while Chandra stands still,” the description reads.
Get MHF Insights
News and tips for your healthcare freedom.
We never spam you. One-step unsubscribe.














